Annual FCF
-$18.88 M
-$4.07 M-27.48%
31 December 2023
Summary:
Gain Therapeutics annual free cash flow is currently -$18.88 million, with the most recent change of -$4.07 million (-27.48%) on 31 December 2023. During the last 3 years, it has fallen by -$6.42 million (-51.54%). GANX annual FCF is now -2409.13% below its all-time high of -$752.50 thousand, reached on 31 December 2018.GANX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$6.08 M
-$298.20 K-5.16%
30 September 2024
Summary:
Gain Therapeutics quarterly free cash flow is currently -$6.08 million, with the most recent change of -$298.20 thousand (-5.16%) on 30 September 2024. Over the past year, it has dropped by -$415.80 thousand (-7.35%). GANX quarterly FCF is now -1332.73% below its all-time high of -$424.10 thousand, reached on 30 June 2020.GANX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$21.10 M
-$2.11 M-11.10%
30 September 2024
Summary:
Gain Therapeutics TTM free cash flow is currently -$21.10 million, with the most recent change of -$2.11 million (-11.10%) on 30 September 2024. Over the past year, it has dropped by -$2.22 million (-11.76%). GANX TTM FCF is now -2684.90% below its all-time high of -$757.70 thousand, reached on 31 March 2020.GANX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GANX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -7.3% | -11.8% |
| 3 y3 years | -51.5% | -46.1% | -69.3% |
| 5 y5 years | -903.1% | - | - |
GANX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -51.5% | at low | -147.5% | at low | -74.7% | at low |
| 5 y | 5 years | -903.1% | at low | -1332.7% | at low | -2684.9% | at low |
| alltime | all time | -2409.1% | at low | -1332.7% | at low | -2684.9% | at low |
Gain Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$6.08 M(+5.2%) | -$21.10 M(+11.1%) |
| June 2024 | - | -$5.78 M(+61.1%) | -$18.99 M(+4.1%) |
| Mar 2024 | - | -$3.59 M(-36.6%) | -$18.24 M(-3.4%) |
| Dec 2023 | -$18.88 M(+27.5%) | -$5.66 M(+42.7%) | -$18.88 M(+10.2%) |
| Sept 2023 | - | -$3.97 M(-21.0%) | -$17.13 M(+3.8%) |
| June 2023 | - | -$5.03 M(+18.8%) | -$16.51 M(-0.4%) |
| Mar 2023 | - | -$4.23 M(+8.0%) | -$16.58 M(+12.0%) |
| Dec 2022 | -$14.81 M(+18.9%) | -$3.91 M(+17.0%) | -$14.81 M(-1.6%) |
| Sept 2022 | - | -$3.35 M(-34.3%) | -$15.05 M(+8.1%) |
| June 2022 | - | -$5.10 M(+107.5%) | -$13.93 M(+15.4%) |
| Mar 2022 | - | -$2.46 M | -$12.08 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$12.46 M(+282.1%) | - | - |
| Dec 2021 | - | -$4.16 M(+86.9%) | -$12.46 M(+29.5%) |
| Sept 2021 | - | -$2.22 M(-31.3%) | -$9.63 M(+18.0%) |
| June 2021 | - | -$3.24 M(+14.1%) | -$8.16 M(+52.7%) |
| Mar 2021 | - | -$2.84 M(+114.6%) | -$5.34 M(+63.8%) |
| Dec 2020 | -$3.26 M(+73.3%) | - | - |
| Dec 2020 | - | -$1.32 M(+74.9%) | -$3.26 M(+68.2%) |
| Sept 2020 | - | -$756.40 K(+78.4%) | -$1.94 M(+64.0%) |
| June 2020 | - | -$424.10 K(-44.0%) | -$1.18 M(+56.0%) |
| Mar 2020 | - | -$757.70 K | -$757.70 K |
| Dec 2019 | -$1.88 M(+150.1%) | - | - |
| Dec 2018 | -$752.50 K | - | - |
FAQ
- What is Gain Therapeutics annual free cash flow?
- What is the all time high annual FCF for Gain Therapeutics?
- What is Gain Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Gain Therapeutics?
- What is Gain Therapeutics quarterly FCF year-on-year change?
- What is Gain Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Gain Therapeutics?
- What is Gain Therapeutics TTM FCF year-on-year change?
What is Gain Therapeutics annual free cash flow?
The current annual FCF of GANX is -$18.88 M
What is the all time high annual FCF for Gain Therapeutics?
Gain Therapeutics all-time high annual free cash flow is -$752.50 K
What is Gain Therapeutics quarterly free cash flow?
The current quarterly FCF of GANX is -$6.08 M
What is the all time high quarterly FCF for Gain Therapeutics?
Gain Therapeutics all-time high quarterly free cash flow is -$424.10 K
What is Gain Therapeutics quarterly FCF year-on-year change?
Over the past year, GANX quarterly free cash flow has changed by -$415.80 K (-7.35%)
What is Gain Therapeutics TTM free cash flow?
The current TTM FCF of GANX is -$21.10 M
What is the all time high TTM FCF for Gain Therapeutics?
Gain Therapeutics all-time high TTM free cash flow is -$757.70 K
What is Gain Therapeutics TTM FCF year-on-year change?
Over the past year, GANX TTM free cash flow has changed by -$2.22 M (-11.76%)